The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Maruho sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Maruho Co Ltd (Maruho) is a pharmaceutical company that researches, develops, produces, and distributes dermatological products. Its product portfolio includes an array of prescription drugs, medical devices and other skincare products. The company also offers products for the treatment of infectious diseases, ophthalmological diseases, ear nose throat disorders, musculoskeletal disorders, central nervous system (CNS) disorders, and cardiovascular, gastrointestinal, and other diseases. Maruho offers prescription drugs in various forms such as ointments, creams, solution, lotions, injections, and gels. The company has manufacturing facilities in Japan, Germany, and the US. Maruho is headquartered in Osaka, Japan. Key subsidiaries of Maruho include Maruho North America, Maruho America, Maeda Pharmaceutical Industry, Tateyama Pharmaceutical Factory and Maruho Hatsujyo Kogyo.
The key metrics of Maruho related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Maruho is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Maruho.
For a detailed understanding of the performance of Maruho, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
